The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 28 Mar 2006
doi: 10.1242/jcs.02857
Research Article
Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex
Luke M. Judge,
Miki Haraguchi,
and
Jeffrey S. Chamberlain*
* Author for correspondence (e-mail: jsc5{at}u.washington.edu)
Duchenne muscular dystrophy is a severe disorder caused by mutations in the dystrophin gene. Dystrophin is required for assembly of the dystrophin-glycoprotein complex and provides a mechanically strong link between the cytoskeleton and the extracellular matrix. Several proteins in the complex also participate in signaling cascades, but the relationship between these signaling and mechanical functions in the development of muscular dystrophy is unclear. To explore the mechanisms of myofiber necrosis in dystrophin-deficient muscle, we tested the hypothesis that restoration of this complex without a link to the cytoskeleton ameliorates dystrophic pathology. Transgenic mice were generated that express Dp116, a non-muscle isoform of dystrophin that assembles the dystrophin-glycoprotein complex, in muscles of dystrophin-deficient mdx4cv mice. However, the phenotype of these mice was more severe than in controls. Displacement of utrophin by Dp116 correlated with the severity of dystrophy in different muscle groups. Comparison with other transgenic lines demonstrated that parts of the dystrophin central rod domain were required to localize neuronal nitric oxide synthase to the sarcolemma, but this was not correlated with presence or extent of dystrophy. Our results suggest that mechanical destabilization, rather than signaling dysfunction, is the primary cause of myofiber necrosis in dystrophin-deficient muscle.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
Y. Jia, R. Warin, X. Yu, R. Epstein, and C. T. Noguchi
Erythropoietin signaling promotes transplanted progenitor cell survival
FASEB J,
September 1, 2009;
23(9):
3089 - 3099.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. W. Prins, J. L. Humston, A. Mehta, V. Tate, E. Ralston, and J. M. Ervasti
Dystrophin is a microtubule-associated protein
J. Cell Biol.,
August 10, 2009;
186(3):
363 - 369.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Li, A. Mittal, D. Y. Makonchuk, S. Bhatnagar, and A. Kumar
Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy
Hum. Mol. Genet.,
July 15, 2009;
18(14):
2584 - 2598.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Colussi, A. Gurtner, J. Rosati, B. Illi, G. Ragone, G. Piaggio, M. Moggio, C. Lamperti, G. D'Angelo, E. Clementi, et al.
Nitric oxide deficiency determines global chromatin changes in Duchenne muscular dystrophy
FASEB J,
July 1, 2009;
23(7):
2131 - 2141.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Li, C. Long, Y. Yue, and D. Duan
Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice
Hum. Mol. Genet.,
April 1, 2009;
18(7):
1209 - 1220.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Lovering, L. Michaelson, and C. W. Ward
Malformed mdx myofibers have normal cytoskeletal architecture yet altered EC coupling and stress-induced Ca2+ signaling
Am J Physiol Cell Physiol,
January 1, 2009;
297(3):
C571 - C580.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K. Peter, J. L. Marshall, and R. H. Crosbie
Sarcospan reduces dystrophic pathology: stabilization of the utrophin-glycoprotein complex
J. Cell Biol.,
November 3, 2008;
183(3):
419 - 427.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Urasawa, M. R. Wada, N. Machida, K. Yuasa, Y. Shimatsu, Y. Wakao, S. Yuasa, T. Sano, I. Nonaka, A. Nakamura, et al.
Selective Vacuolar Degeneration in Dystrophin-Deficient Canine Purkinje Fibers Despite Preservation of Dystrophin-Associated Proteins With Overexpression of Dp71
Circulation,
May 13, 2008;
117(19):
2437 - 2448.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Li, Y. Yue, and D. Duan
Preservation of Muscle Force in Mdx3cv Mice Correlates with Low-Level Expression of a Near Full-Length Dystrophin Protein
Am. J. Pathol.,
May 1, 2008;
172(5):
1332 - 1341.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G. Reynolds, S. A. McCalmon, J. A. Donaghey, and F. J. Naya
Deregulated Protein Kinase A Signaling and Myospryn Expression in Muscular Dystrophy
J. Biol. Chem.,
March 28, 2008;
283(13):
8070 - 8074.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E. Adams, Y. Tesch, J. M. Percival, D. E. Albrecht, J. I. Conhaim, K. Anderson, and S. C. Froehner
Differential targeting of nNOS and AQP4 to dystrophin-deficient sarcolemma by membrane-directed {alpha}-dystrobrevin
J. Cell Sci.,
January 1, 2008;
121(1):
48 - 54.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. B. Banks, P. Gregorevic, J. M. Allen, E. E. Finn, and J. S. Chamberlain
Functional capacity of dystrophins carrying deletions in the N-terminal actin-binding domain
Hum. Mol. Genet.,
September 1, 2007;
16(17):
2105 - 2113.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G. Tidball and M. Wehling-Henricks
The role of free radicals in the pathophysiology of muscular dystrophy
J Appl Physiol,
April 1, 2007;
102(4):
1677 - 1686.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K. Peter, G. Miller, and R. H. Crosbie
Disrupted mechanical stability of the dystrophin-glycoprotein complex causes severe muscular dystrophy in sarcospan transgenic mice
J. Cell Sci.,
March 15, 2007;
120(6):
996 - 1008.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Duan
Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy
Hum. Mol. Genet.,
October 15, 2006;
15(suppl_2):
R253 - R261.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2006
